#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease Acute graft versus host disease in liver Peritoneal mesothelioma malignant Acute promyelocytic leukaemia Myxoid liposarcoma Congenital disorder of glycosylation Congenital aplastic anaemia Hereditary neuropathic amyloidosis Staphylococcal infection Infantile spasms Thrombotic microangiopathy Osteopetrosis Hyperphagia Chorioretinitis Nasopharyngeal cancer More trials…

    Learn about Rare Diseases

    Castleman’s disease – Diagnostics Idiopathic inflammatory myopathy – Treatment Leiomyosarcoma – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Prader-Willi syndrome – Basic Information Leiomyosarcoma metastatic – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Alagille syndrome – Diagnostics Sjogren’s syndrome – Treatment Osteosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Folic Acid, Anhydrous Betula Verrucosa (108) Bexmarilimab Polydextrose Teprotumumab Obefazimod Tasimelteon ABY-271 Sodium Acetate (1-13C) Sufentanil Citrate Fidanacogene Elaparvovec Human Coagulation Factor Ix Englumafusp Alfa A3907 YL201 Ads-010 Cholic Acid Ruxotemitide S230815-2 RIMIDUCID More therapies…

    Learn about Your Condition

    Vertebrobasilar stroke Liver transplant rejection Indolent systemic mastocytosis Colorectal cancer stage II Critical illness Gaucher's disease type III Gender dysphoria Hepatitis D Chondrocalcinosis Atrial fibrillation Hyperkalaemia Chronic hepatitis C Lymphangiosarcoma Hot flush Breast cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastric cancer

  • 68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Gallium (68Ga) Chloride
    • Germanium (68Ge) Chloride
    France

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    • Endometrial cancer
    • Cervix carcinoma
    Investigated Drugs:
    • SGN-ALPV
    Denmark The Netherlands Spain Sweden

  • Study on Preoperative Iron Infusion with Ferric Carboxymaltose for Patients with Stomach Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Finland

  • Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Pancreatic carcinoma
    • Gastric cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany

  • Study of Disitamab Vedotin and Tucatinib for Patients with Advanced Breast Cancer or Gastric Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Tucatinib
    • Disitamab Vedotin
    France Germany Italy Spain

  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cldn6 Car-T
    • Cldn6 Car-T(A)
    • Cldn6 Rna-Lpx
    Germany The Netherlands Sweden
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!